Anal Fistula Treatment Market to Reach US$ 920.2 Mn by End of 2031, Transparency Market Research Inc.

In 2022, the market size for 𝐚𝐧𝐚𝐥 𝐟𝐢𝐬𝐭𝐮𝐥𝐚 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 reached US$ 650.9 million. Over the period from 2023 to 2031, it is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 3.8%, eventually reaching US$ 920.2 million by the end of 2031.

The growth of the anal fistula treatment market is being propelled by factors such as unhygienic toilet habits and unhealthy dietary practices. Modern lifestyles characterized by fast-paced living have led individuals to neglect their dietary choices, resulting in an increased consumption of junk food. Additionally, the prevalence of sexually transmitted diseases (STDs) is contributing to the rising demand for anal fistula treatment.

𝐑𝐞𝐜𝐞𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36980&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧

Anal fistula treatment typically involves creating a connection between an infected cavity or abscess in the anal region and the outer skin to drain pus. Perianal abscess therapy is usually the initial treatment option, with surgical intervention recommended in specific cases, such as when the patient is febrile, elderly, hypotensive, or has significant comorbidities.

Minimally invasive techniques, including laser treatment, may replace traditional surgical correction in some instances, alongside the use of herbal medicines under healthcare professional guidance. Fistulectomy, involving the removal of the fistula tract, aims to promote healing and prevent recurrence. Rectal fistula management is advised for patients unable to tolerate surgical procedures due to pain.

However, the lack of awareness regarding the importance of anal fistula treatment in developing economies, particularly in the Asia Pacific and Middle East & Africa regions, is expected to hinder market growth during the forecast period.

𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:

Aditya Birla Chemicals Ltd., Kemira Oyj, Akzo Nobel NV, Evonik Industries AG, Merck & Co. Inc., Arkema S.A., Solvay SA, The Dow Chemical Company, Hawkins, Inc., and Spartan Chemical Company, Inc. 

𝐀𝐧𝐚𝐥 𝐅𝐢𝐬𝐭𝐮𝐥𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

Treatment Type

Non-surgical (Drugs and Others (fibrin glue, adipose stem cell therapy, etc.)
Surgical (Fistulotomy, Bioprosthetic Plugs, Advancement Flap Procedures, Seton techniques, and Others)

Application

Intersphincteric
Transsphincteric
Suprasphincteric
Extrasphincteric
Others

End-user

Hospitals & Ambulatory Surgical Centers
Clinics
Others

𝐑𝐢𝐬𝐞 𝐢𝐧 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐒𝐚𝐟𝐞 𝐚𝐧𝐝 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐰𝐢𝐭𝐡 𝐍𝐞𝐠𝐥𝐢𝐠𝐢𝐛𝐥𝐞 𝐑𝐞𝐜𝐮𝐫𝐫𝐞𝐧𝐜𝐞 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐀𝐧𝐚𝐥 𝐅𝐢𝐬𝐭𝐮𝐥𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐚𝐥𝐮𝐞

The surge in demand for highly effective treatments with minimal recurrence rates is driving key players to introduce state-of-the-art medications and equipment. Advanced laser treatments for anal fistulas utilize minimally invasive techniques, such as emitting laser beams into the fistula track to induce tissue shrinkage, leading to fistula closure. Additionally, endorectal flaps are employed for internal opening closure.

Another advanced treatment option involves using fibrin glue, where the surgeon injects the glue into the fistula under general anesthesia, aiding in fistula sealing.

Surgical approaches to anal fistula treatment are complemented by holistic post-surgery care, including dietary recommendations for fiber-rich foods and hydration to cultivate proper bowel habits. Innovative herbal remedies, such as honey or flaxseed intake and coconut or Oregano oil application, are also advocated.

Combining different treatment modalities, such as drainage Seton procedures and LIFT-plug, enhances treatment effectiveness. The availability of diverse treatment options is expected to drive demand in the anal fistula treatment market during the forecast period.

𝐆𝐫𝐚𝐛 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=36980<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

-Shift towards minimally invasive treatment options
-Development of novel pharmaceutical therapies
-Integration of advanced technologies in surgical procedures

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In March 2022, Ossium Health, Inc. received approval from the US FDA for its Investigational New Drug (IND) application for OSSM-001, one of the mesenchymal stem cell (MSC) products to treat refractory perianal fistulas in those suffering from Crohn's disease.

In February 2022, Takeda, released its first 6-month interim analysis results provided by INSPIRE, which stated that clinical remission was seen in 65% of patients in two cohorts evaluated at 6 months. INSPIRE is a Europe-based multicentre, observational, open-enrollment, post-approval study (EUPAS24267) that evaluates real-world safety and effectiveness of Alofisel (darvadstrocel) in patients contracting complex perianal fistulas and Crohn's disease.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

-Prevalence and incidence rates of anal fistulas
-Treatment preferences among healthcare providers and patients
-Technological advancements in treatment modalities
-Regulatory landscape and reimbursement policies
-Competitive landscape and market dynamics

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐂𝐚𝐥𝐜𝐢𝐮𝐦 𝐂𝐚𝐫𝐛𝐢𝐝𝐞 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/02/2619470/0/en/Calcium-Carbide-Market-to-Reach-US-31-Bn-by-End-of-2031-Transparency-Market-Research-Inc.html

𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/03/03/2620550/0/en/Influenza-Vaccine-Market-Size-to-Exceed-US-7-2-Bn-by-2031-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.